Calliditas Therapeutics Ab (CALT) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Calliditas Therapeutics Ab  (NASDAQ: CALT)


Calliditas Therapeutics Ab's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Calliditas Therapeutics Ab's ROI in the second quarter of 2024?
Calliditas Therapeutics Ab recorded a cumulative net loss of $-63 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -149.73%.

Within the Healthcare sector 955 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 4727 to 5627.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM -57.61 % -91.59 % -89.52 % -70.92 % -51.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 124 41 2 2 2
Return On Investment (TTM) -149.73 % -505.66 % -238.41 % -87 % -64.06 %
CALT's Overall Ranking # 5627 # 4727 # 0 # 0 #
Seq. Investment Change TTM 263.2 % -47.7 % -63.51 % -38.84 % -27.98 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -63 -59 -53 -53 -64

CALT Company Profile >> Back to CALT Roi Comparisons >> See Annual CALT Return On Investment



Return On Investment CALT's Ranking
Within: No.
Industry # 467
Sector # 956
Overall # 5627

Return On Investment Statistics
High Average Low
-28.29 %
-1437.09 %
-2845.89 %
(Dec 31 2022)   (Dec 31 2023)







Financial Statements
Calliditas Therapeutics Ab's II. Quarter Investments $ 124 Millions CALT's Balance sheet
Calliditas Therapeutics Ab's II. Quarter Income $ -4 Millions Quarterly CALT's Income Statement
CALT's Income by Division See CALT's Income by Division


CALT Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2018)
2020
Total Investments in Millions 41 157 146 159 0
Y / Y Investment Growth -73.66 % 7.06 % -8.05 % - -
Net Income in Millions -44 -41 -59 -48 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -106.56 % -26.11 % -40.6 % -29.86 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CALT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CALT's Competitors
Subscribers only: Roi for Calliditas Therapeutics Ab's Suppliers
Subscribers only: Return On Investment for CALT's Customers

Other Ratios
CALT's Roa CALT's Inventory Turnover Ratio CALT's Growth Rates CALT's Dividend Statistics
CALT's Profitability Ratios CALT's Asset Turnover Ratio CALT's Dividend Growth
CALT's Roe CALT's Valuation Ratios CALT's Financial Strength Ratios CALT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-30T13:42:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.